Metabolic syndrome in children

Area of Science:

• Pediatric Endocrinology
• Metabolic Disorders
• Pharmacology

Background:

• Metabolic syndrome (MetS) in children and adolescents presents diagnostic and therapeutic challenges.
• Current lifestyle interventions (diet, exercise) for pediatric MetS often yield suboptimal outcomes, particularly in adolescents.
• Uncertainties persist regarding the definition, prevention, and management of MetS in pediatric populations.

Purpose of the Study:

• To review recent therapeutic strategies for pediatric metabolic syndrome, emphasizing insulin resistance.
• To discuss the role of pharmacological interventions and bariatric surgery in managing pediatric MetS.
• To briefly address the management of congenital forms of insulin resistance.

Main Methods:

• Literature review of recent studies on pediatric metabolic syndrome treatments.
• Analysis of pharmacological interventions, including Metformin and emerging therapies.
• Inclusion of data on lifestyle modifications and surgical options.

Main Results:

• Metformin demonstrates safety and positive effects on insulin sensitivity in obese children, though long-term pediatric data is limited.
• Emerging treatments like GLP-1 analogues, DPP-4 inhibitors, SGLT inhibitors, and weight loss drugs require further investigation for pediatric efficacy.
• Bariatric surgery may be a viable option for select pediatric cases.

Conclusions:

• Evidence supports Metformin's short-term benefits for pediatric insulin resistance, but long-term data is crucial.
• Further research is needed to establish the efficacy and safety of newer pharmacologic agents and weight loss drugs in children.
• A multimodal approach, including lifestyle changes, pharmacotherapy, and potentially surgery, is essential for managing pediatric metabolic syndrome.